KALA BIO, Inc.
KALA
$2.93
-$0.16-5.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 117.45% | -2.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.09% | -1.97% | |||
| Operating Income | 4.09% | 1.97% | |||
| Income Before Tax | 109.07% | 32.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 109.07% | 32.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 109.07% | 32.19% | |||
| EBIT | 4.09% | 1.97% | |||
| EBITDA | 3.44% | 2.54% | |||
| EPS Basic | 105.04% | 37.29% | |||
| Normalized Basic EPS | 59.78% | 7.65% | |||
| EPS Diluted | 105.04% | 37.29% | |||
| Normalized Diluted EPS | 59.78% | 7.65% | |||
| Average Basic Shares Outstanding | 80.11% | 8.13% | |||
| Average Diluted Shares Outstanding | 80.11% | 8.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||